Literature DB >> 12865091

Nitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monniera.

Alessandra Russo1, Francesca Borrelli, Agata Campisi, Rosaria Acquaviva, Giuseppina Raciti, Angelo Vanella.   

Abstract

There is growing evidence that high concentrations of nitric oxide (NO), generated by activated astrocytes, might be involved in a variety of neurodegenerative diseases, such as Alzheimer's disease, ischemia and epilepsy. It has recently been suggested that glial cells may produce NO under superoxide radical stimulation by enzyme-independent mechanism. This suggests that also natural antioxidants may have therapeutical relevance in neurodegenerative diseases. Studies of Bhattacharya et al. have evidenced that Bacopa monniera (BM) (family Scrophulariaceae), an Ayurvedic medicinal plant clinically used for memory enhancing, epilepsy, insomnia and as a mild sedative, is able to reduce the memory-dysfunction in rat models of Alzheimer's disease, but the molecular mechanisms of this action are yet to be determined. In the present study, we examined the effect of a methanolic extract of BM on toxicity induced by the nitric oxide donor, S-nitroso-N-acetyl-penicillamine (SNAP), in culture of purified rat astrocytes. Our results indicate that, after 18 h of treatment, SNAP induced an increase in the production of reactive species, but did not induce the rupture of cellular membrane. Conversely, this NO donor induced a fragmentation of genomic DNA compared to control astrocytes. The extract of BM inhibited the formation of reactive species and DNA damage in a dose dependent manner. This data supports the traditional use of BM and indicates that this medicinal plant has a therapeutic potential in treatment or prevention of neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865091     DOI: 10.1016/s0024-3205(03)00476-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  22 in total

1.  Amelioration of age associated neuroinflammation on long term bacosides treatment.

Authors:  Manisha Rastogi; Rudra P Ojha; B Parimala Devi; Aabha Aggarwal; Aruna Agrawal; G P Dubey
Journal:  Neurochem Res       Date:  2011-12-25       Impact factor: 3.996

2.  Cytoprotective propensity of Bacopa monniera against hydrogen peroxide induced oxidative damage in neuronal and lung epithelial cells.

Authors:  M D Pandareesh; T Anand; Pratiksha V Bhat
Journal:  Cytotechnology       Date:  2014-07-26       Impact factor: 2.058

Review 3.  Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's Disease.

Authors:  Kaustubh S Chaudhari; Nishant R Tiwari; Rakesh R Tiwari; Rohan S Sharma
Journal:  Ann Neurosci       Date:  2017-05-12

4.  Behavioral deficit and decreased GABA receptor functional regulation in the hippocampus of epileptic rats: effect of Bacopa monnieri.

Authors:  Jobin Mathew; Gireesh Gangadharan; Korah P Kuruvilla; C S Paulose
Journal:  Neurochem Res       Date:  2010-09-07       Impact factor: 3.996

Review 5.  The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.

Authors:  John E Lewis; Jillian Poles; Delaney P Shaw; Elisa Karhu; Sher Ali Khan; Annabel E Lyons; Susana Barreiro Sacco; H Reginald McDaniel
Journal:  J Clin Transl Res       Date:  2021-08-04

Review 6.  Neuropharmacological review of the nootropic herb Bacopa monnieri.

Authors:  Sebastian Aguiar; Thomas Borowski
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

7.  Chemopreventive effect of bacoside A on N-nitrosodiethylamine-induced hepatocarcinogenesis in rats.

Authors:  Panneerselvam Janani; Kanakarajan Sivakumari; Arumugam Geetha; Baskaran Ravisankar; Chandrakesan Parthasarathy
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-15       Impact factor: 4.553

8.  A randomized controlled trial investigating the effect of Pycnogenol and Bacopa CDRI08 herbal medicines on cognitive, cardiovascular, and biochemical functioning in cognitively healthy elderly people: the Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910).

Authors:  Con K Stough; Matthew P Pase; Vanessa Cropley; Stephen Myers; Karen Nolidin; Rebecca King; David Camfield; Keith Wesnes; Andrew Pipingas; Kevin Croft; Dennis Chang; Andrew B Scholey
Journal:  Nutr J       Date:  2012-03-06       Impact factor: 3.271

Review 9.  Bacopa monnieri as an Antioxidant Therapy to Reduce Oxidative Stress in the Aging Brain.

Authors:  Tamara Simpson; Matthew Pase; Con Stough
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-27       Impact factor: 2.629

10.  Bacopa monnieri protects SH-SY5Y cells against tert-Butyl hydroperoxide-induced cell death via the ERK and PI3K pathways.

Authors:  Kanoktip Petcharat; Meharvan Singh; Kornkanok Ingkaninan; Jongrak Attarat; Sukkid Yasothornsrikul
Journal:  Siriraj Med J       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.